Splenomegaly during oxaliplatin-based chemotherapy: impact on blood parameters and anti-neoplastic treatment

BACKGROUND: Oxaliplatin induces splenomegaly, which can cause blood sequestration and relevant cytopenia, leading to further dose reductions and schedule modifications of chemotherapy. Here, we aimed to explore the changes of spleen volume induced by oxaliplatin as well as its impact on blood parame...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Ruoyu, Huang, Guanghua, Xu, Jing, Yu, Xiaoduo, Zhou, Aiping, Du, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560872/
https://www.ncbi.nlm.nih.gov/pubmed/36249886
http://dx.doi.org/10.21037/tcr-22-83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560872/
https://www.ncbi.nlm.nih.gov/pubmed/36249886
http://dx.doi.org/10.21037/tcr-22-83

Ejemplares similares